| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.986 | 0.002 | 0.986 | Platelet antagonist | 0.971 0.002 CID_154699881 | ||
| 0.977 | 0.002 | 0.977 | Platelet aggregation inhibitor | 0.959 0.003 CID_154699881 | ||
| 0.89 | 0.001 | 0.89 | Platelet adhesion inhibitor | 0.825 0.002 CID_154699881 | ||
| 0.772 | 0.002 | 0.772 | Hemostatic | |||
| 0.762 | 0.005 | 0.762 | Antithrombotic | 0.588 0.017 CID_154699881 | ||
| 0.498 | 0.002 | 0.6 | Purinergic P2T antagonist | 0.6 0.002 CID_154699881 | CID_154699881 | |
| 0.407 | 0.005 | 0.407 | Sigma receptor antagonist | |||
| 0.169 | 0.021 | 0.169 | Papain-like protease (SARS coronavirus) inhibitor | 0.162 0.024 CID_154699881 | ||
| 0.058 | 0.008 | 0.058 | Phenylethanolamine N methyltransferase inhibitor | |||
| 0.052 | 0.006 | 0.224 | Purinergic P2Y12 antagonist | 0.224 0.004 CID_154699881 | CID_154699881 | |
| 0.022 | 0.073 | 0.039 | Purinergic P2Y antagonist | 0.039 0.038 CID_154699881 | CID_154699881 | |
| 0.033 | 0.101 | 0.09 | Purinergic P2 antagonist | 0.09 0.026 CID_154699881 | CID_154699881 | |
| 0.004 | 0.2 | 0.029 | Aminopeptidase P inhibitor | 0.029 0.01 CID_154699881 | CID_154699881 | |
| 0.009 | 0.4 | 0.109 | Endothelin-converting enzyme inhibitor | 0.109 0.013 CID_154699881 | CID_154699881 | |
| 0.025 | 0.91 | 0.14 | Factor V inhibitor | 0.14 0.023 CID_154699881 | CID_154699881 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |